Ryan Matherly
Family Medicine · Elkhart, INNPI 1356344972
Payments from drug & device makers
Across 121 payments — averaging $12.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$365
- GSK$142
- Novo Nordisk$139
- Sunovion Pharmaceuticals Inc.$135
- AbbVie$122
- Merck$110
- plus $514 from 16 others
What the payments were for
- Food & beverage$1,526100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 19 | $365 |
| GSK | 5 | $142 |
| Novo Nordisk | 26 | $139 |
| Sunovion Pharmaceuticals Inc. | 12 | $135 |
| AbbVie(2 entities) | 8 | $122 |
| Merck | 13 | $110 |
| Pfizer | 5 | $65 |
| Novartis | 4 | $54 |
| Johnson & Johnson | 4 | $53 |
| Astellas Pharma US Inc | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $40 |
| AstraZeneca | 3 | $39 |
| Amarin Pharma, Inc. | 3 | $36 |
| Alkermes, Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Boehringer Ingelheim | 2 | $26 |
| Lilly USA, LLC | 2 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Vyera Pharmaceuticals, LLC | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| MDD US Operations, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEXSERO$100
How this compares
$1,526 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olmesartan Medoxomil | 24 | $264 |
| Amlodipine Besylate | 23 | $155 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Elkhart
- Vikram MehtaElkhart$24K
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.